Expanded Access to Mepsevii
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorUltragenyx Pharmaceutical Inc
About this trial
Individual patient expanded access requests may be considered for patients who have no other treatment options
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Mepsevii
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov